Cytotheryx

Cytotheryx is a preclinical cell therapy company leveraging proprietary technology to treat acute, chronic, and rare hereditary liver diseases. As a spin-off from the Mayo Clinic, Cytotheryx has developed a differentiated platform capable of scalable production of clinically relevant, fully functional primary human hepatocytes for therapeutic use.